Atrial fibrillation (AF) is associated with cognitive decline, even in the absence of clinical stroke. The Swiss AF Cohort (SWISS-AF) study sought to quantify the incidence of silent brain infarcts in patients with AF. Investigators then explored the relationship between silent brain infarcts and cognitive decline. Finally, they also examined if anticoagulation seemed to have … [Read more...] about Change in cognitive function in atrial fibrillation patients
General cardiology
Greater risk of death in heart failure patients hospitalized for COVID-19
The CAPACITY-COVID Collaborative Consortium and LEOSS Study Group examined outcomes of hospitalized COVID-19 patients, both with and without pre-existing heart disease. The CAPACITY-COVID (NCT04325412) registry was launched in March 2020 and has collected data from adults hospitalized for COVID-19 from 74 centres across 13 countries across Europe. The Lean Open Survey on … [Read more...] about Greater risk of death in heart failure patients hospitalized for COVID-19
Empagliflozin and Renal Outcomes in Heart Failure
The EMPEROR-Reduced (NCT03057977) and EMPEROR-Preserved (NCT03057951) trials demonstrated that empagliflozin could reduce the risk of hospitalization for heart failure (HF) both in patients with HF and reduced left ventricular ejection fraction (LVEF) and patients with HF and preserved LVEF. However, the effect of empagliflozin on renal function is unknown. Investigators … [Read more...] about Empagliflozin and Renal Outcomes in Heart Failure
Top Highlights of ACC 2022
The American College of Cardiology (ACC) 2022 Scientific Session was a hybrid event which took place from April 2 to 4, 2022, in Washington, USA and online. Here is the curated list of the top highlights of the ACC 2022 sessions. SODIUM-HF trial1: This international trial (NCT02012179) followed 806 adult patients with chronic heart failure (CHF) receiving optimally … [Read more...] about Top Highlights of ACC 2022
Cardiovascular sequelae in COVID-19 survivors
Cardiovascular (CV) events associated with acute COVID-19 infection include myocardial infarction (MI), arrhythmias, multisystem inflammatory syndrome, stroke, embolism, and bleeding disorders. Some patients who recover from acute COVID-19 suffer ongoing health challenges. Satterfield et. al. propose 4 categories to consider CV sequelae in COVID survivors. Asymptomatic, … [Read more...] about Cardiovascular sequelae in COVID-19 survivors